BIOMAT Database Logo BIOMAT Database Logo

Drug interactions with new and investigational antiretrovirals. 2010

Herta M Crauwels, and Thomas N Kakuda

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068696 Rilpivirine A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone. R278474,Rilpivirine HCl,Rilpivirine Hydrochloride,TMC 278,TMC-278,TMC278,278, TMC,HCl, Rilpivirine,Hydrochloride, Rilpivirine
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Herta M Crauwels, and Thomas N Kakuda
Drug interactions with new and investigational antiretrovirals.
January 2009, Clinical pharmacokinetics,
Herta M Crauwels, and Thomas N Kakuda
Drug interactions with antiretrovirals.
June 2004, Current HIV/AIDS reports,
Herta M Crauwels, and Thomas N Kakuda
Drug Interactions with Antiretrovirals.
June 2000, Current infectious disease reports,
Herta M Crauwels, and Thomas N Kakuda
Drug interactions with antiretrovirals and warfarin.
March 2010, Expert opinion on drug safety,
Herta M Crauwels, and Thomas N Kakuda
[Antiretrovirals: drug and food interactions].
September 2020, Revue medicale suisse,
Herta M Crauwels, and Thomas N Kakuda
Review of drug interactions with telaprevir and antiretrovirals.
January 2013, Antiviral therapy,
Herta M Crauwels, and Thomas N Kakuda
Pharmacology and drug interactions: compartmentalizing antiretrovirals.
March 2000, The Hopkins HIV report : a bimonthly newsletter for healthcare providers,
Herta M Crauwels, and Thomas N Kakuda
Drug Interactions Among the Antiretrovirals.
April 2004, Current infectious disease reports,
Herta M Crauwels, and Thomas N Kakuda
Significant interactions with new antiretrovirals and psychotropic drugs.
April 1999, The Annals of pharmacotherapy,
Herta M Crauwels, and Thomas N Kakuda
Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse.
January 2005, Psychosomatics,
Copied contents to your clipboard!